|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 108, Issue 12 3649-3659, Copyright © 1995 by Company of Biologists
JOURNAL ARTICLES |
L Blavier and JM Delaisse
Laboratoire de Chimie Physiologique (Connective Tissue Group), Universite de Louvain, Bruxelles, Belgium.
A key event in bone resorption is the recruitment of osteoclasts to future resorption sites. We follow here the migration of preosteoclasts from the periosteum to the developing marrow cavity of fetal mouse metatarsals in culture, and investigate the role of proteinases and demineralization in this migration. Our approach consisted in testing inhibitors of proteinases and demineralization on the migration kinetics. Migration was monitored by histomorphometry and the (pre)osteoclasts were identified by their tartrate resistant acid phosphatase (TRAP) activity. At the time of explantation, TRAP+ cells (all mononucleated) are detected only in the periosteum, and the core of the diaphysis (future marrow cavity) consist of calcified cartilage. Upon culture, TRAP+ cells (differentiating progressively into multinucleated osteoclasts) migrate through a seam of osteoid and a very thin and discontinuous layer of mineral, invade the calcified cartilage and transform it into a "marrow' cavity; despite the passage of maturing osteoclasts, the osteoid develops into a bone collar. The migration of TRAP+ cells is completely prevented by matrix metalloproteinase (MMP) inhibitors, but not by a cysteine proteinase inhibitor, an inhibitor of carbonic anhydrase, or a bisphosphonate. The latter three drugs inhibit, however, the resorptive activity of mature osteoclasts at least as efficiently as do the MMP inhibitors, as assessed in cultures of calvariae and radii. Furthermore, in situ hybridizations reveal the expression of 2 MMPs, gelatinase B (MMP-9 or 92 kDa type IV collagenase) in (pre)osteoclasts, and interstitial collagenase (MMP-13) in hypertrophic chondrocytes. It is concluded that only MMPs appear obligatory for the migration of (pre)osteoclasts, and that this role is distinct from the one MMPs may play in the subosteoclastic resorption compartment. We propose that this new role of MMPs is a major component of the mechanism that determines where and when the osteoclasts will attack the bone.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  V.D. La, A.B. Howell, and D. Grenier Cranberry Proanthocyanidins Inhibit MMP Production and Activity Journal of Dental Research, July 1, 2009; 88(7): 627 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Hillegass, C. M. Villano, K. R. Cooper, and L. A. White Matrix Metalloproteinase-13 Is Required for Zebra fish (Danio rerio) Development and Is a Target for Glucocorticoids Toxicol. Sci., November 1, 2007; 100(1): 168 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Taniguchi, K. Yoshida, T. Ito, M. Tsuda, Y. Mishima, T. Furumatsu, L. Ronfani, K. Abeyama, K.-i. Kawahara, S. Komiya, et al. Stage-Specific Secretion of HMGB1 in Cartilage Regulates Endochondral Ossification Mol. Cell. Biol., August 15, 2007; 27(16): 5650 - 5663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zaragoza, E. Lopez-Rivera, C. Garcia-Rama, M. Saura, A. Martinez-Ruiz, T. R. Lizarbe, F. Martin-de-Lara, and S. Lamas Cbfa-1 mediates nitric oxide regulation of MMP-13 in osteoblasts. J. Cell Sci., May 1, 2006; 119(Pt 9): 1896 - 1902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ljusberg, Y. Wang, P. Lang, M. Norgard, R. Dodds, K. Hultenby, B. Ek-Rylander, and G. Andersson Proteolytic Excision of a Repressive Loop Domain in Tartrate-resistant Acid Phosphatase by Cathepsin K in Osteoclasts J. Biol. Chem., August 5, 2005; 280(31): 28370 - 28381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kananen, L. Volin, K. Laitinen, H. Alfthan, T. Ruutu, and M. J. Valimaki Prevention of Bone Loss after Allogeneic Stem Cell Transplantation by Calcium, Vitamin D, and Sex Hormone Replacement with or without Pamidronate J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3877 - 3885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ortega, D. J. Behonick, C. Colnot, D. N.W. Cooper, and Z. Werb Galectin-3 Is a Downstream Regulator of Matrix Metalloproteinase-9 Function during Endochondral Bone Formation Mol. Biol. Cell, June 1, 2005; 16(6): 3028 - 3039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Dong, R. D. Bonfil, S. Chinni, X. Deng, J. C. Trindade Filho, M. Bernardo, U. Vaishampayan, M. Che, B. F. Sloane, S. Sheng, et al. Matrix Metalloproteinase Activity and Osteoclasts in Experimental Prostate Cancer Bone Metastasis Tissue Am. J. Pathol., April 1, 2005; 166(4): 1173 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wang, H. Yamamoto, J. R. Chin, Z. Werb, and T. H. Vu Epidermal Growth Factor Receptor-deficient Mice Have Delayed Primary Endochondral Ossification Because of Defective Osteoclast Recruitment J. Biol. Chem., December 17, 2004; 279(51): 53848 - 53856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Henriksen, M. Karsdal, J.-M. Delaisse, and M. T. Engsig RANKL and Vascular Endothelial Growth Factor (VEGF) Induce Osteoclast Chemotaxis through an ERK1/2-dependent Mechanism J. Biol. Chem., December 5, 2003; 278(49): 48745 - 48753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. van der Pluijm, M. Deckers, B. Sijmons, H. de Groot, J. Bird, R. Wills, S. Papapoulos, A. Baxter, and C. Lowik In Vitro and in Vivo Endochondral Bone Formation Models Allow Identification of Anti-Angiogenic Compounds Am. J. Pathol., July 1, 2003; 163(1): 157 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Atkinson and R. M. Senior Matrix Metalloproteinase-9 in Lung Remodeling Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 12 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R L van Bezooijen, L van der Wee-Pals, S E Papapoulos, and C W G M Lowik Interleukin 17 synergises with tumour necrosis factor {alpha} to induce cartilage destruction in vitro Ann Rheum Dis, October 1, 2002; 61(10): 870 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Spessotto, F. M. Rossi, M. Degan, R. Di Francia, R. Perris, A. Colombatti, and V. Gattei Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9 J. Cell Biol., September 16, 2002; 158(6): 1133 - 1144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Arai, O. Ohneda, T. Miyamoto, X. Q. Zhang, and T. Suda Mesenchymal Stem Cells in Perichondrium Express Activated Leukocyte Cell Adhesion Molecule and Participate in Bone Marrow Formation J. Exp. Med., June 17, 2002; 195(12): 1549 - 1563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Winding, R. NicAmhlaoibh, H. Misander, P. Hoegh-Andersen, T. L. Andersen, C. Holst-Hansen, A.-M. Heegaard, N. T. Foged, N. Brunner, and J.-M. Delaisse Synthetic Matrix Metalloproteinase Inhibitors Inhibit Growth of Established Breast Cancer Osteolytic Lesions and Prolong Survival in Mice Clin. Cancer Res., June 1, 2002; 8(6): 1932 - 1939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Nemeth, R. Yousif, M. Herzog, M. Che, J. Upadhyay, B. Shekarriz, S. Bhagat, C. Mullins, R. Fridman, and M. L. Cher Matrix Metalloproteinase Activity, Bone Matrix Turnover, and Tumor Cell Proliferation in Prostate Cancer Bone Metastasis J Natl Cancer Inst, January 2, 2002; 94(1): 17 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pfaff and P. Jurdic Podosomes in osteoclast-like cells: structural analysis and cooperative roles of paxillin, proline-rich tyrosine kinase 2 (Pyk2) and integrin {alpha}V{beta}3 J. Cell Sci., January 8, 2001; 114(15): 2775 - 2786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Engsig, Q.-J. Chen, T. H. Vu, A.-C. Pedersen, B. Therkidsen, L. R. Lund, K. Henriksen, T. Lenhard, N. T. Foged, Z. Werb, et al. Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones J. Cell Biol., November 13, 2000; 151(4): 879 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Vu and Z. Werb Matrix metalloproteinases: effectors of development and normal physiology Genes & Dev., September 1, 2000; 14(17): 2123 - 2133. [Full Text]
|
|
|
|
 |
|
 S. Boissier, M. Ferreras, O. Peyruchaud, S. Magnetto, F. H. Ebetino, M. Colombel, P. Delmas, J.-M. Delaisse, and P. Clezardin Bisphosphonates Inhibit Breast and Prostate Carcinoma Cell Invasion, an Early Event in the Formation of Bone Metastases Cancer Res., June 1, 2000; 60(11): 2949 - 2954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. EVERTS, W. KORPER, D. C. JANSEN, J. STEINFORT, I. LAMMERSE, S. HEERA, A. J. P. DOCHERTY, and W. BEERTSEN Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone FASEB J, July 1, 1999; 13(10): 1219 - 1230. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. G. Jimenez, M. Balbin, J. M. Lopez, J. Alvarez, T. Komori, and C. Lopez-Otin Collagenase 3 Is a Target of Cbfa1, a Transcription Factor of the runt Gene Family Involved in Bone Formation Mol. Cell. Biol., June 1, 1999; 19(6): 4431 - 4442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Hill, A. Tumber, S. Papaioannou, and M. C. Meikle The Cellular Actions of Interleukin-11 on Bone Resorption in Vitro Endocrinology, April 1, 1998; 139(4): 1564 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Jemtland, K. Lee, and G. V. Segre Heterogeneity Among Cells That Express Osteoclast-Associated Genes in Developing Bone Endocrinology, January 1, 1998; 139(1): 340 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Newberry, D. Willis, T. Latifi, J. M. Boudreaux, and D. A. Towler Fibroblast Growth Factor Receptor Signaling Activates the Human Interstitial Collagenase Promoter via the Bipartite Ets-AP1 Element Mol. Endocrinol., July 1, 1997; 11(8): 1129 - 1144. [Abstract] [Full Text]
|
|
|
|
|
|
T Sato, M del Carmen Ovejero, P Hou, A. Heegaard, M Kumegawa, N. Foged, and J. Delaisse Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts J. Cell Sci., January 3, 1997; 110(5): 589 - 596. [Abstract] [PDF]
|
|
